Selective tumor lysis by charge-alternating spherical membrane-lytic peptide bottlebrushes via redox backbone degradation and pH-gated unmasking

Key Points

• Selective tumor lysis is achieved through charge-alternating membrane-lytic peptides, enhancing therapeutic specificity.
• Redox backbone degradation and pH-triggered mechanisms are critical for effective tumor targeting and lysis.
• This study utilizes synthetic bottlebrush architectures to improve peptide performance in tumor environments.
• Results indicate potential clinical applications in targeted cancer therapy, requiring further validation in diverse models.